Epic Sciences

Epic Sciences, a US-based liquid biopsy and cancer treatment technology developer, focuses on building a profiling diagnostics platform for the identification and characterization of rare cells, including circulating tumor cells (CTC). Its No Cell Left Behind technology helps match patients with targeted therapies and monitor drug resistance, enabling effective treatment options to be selected at every clinical decision point.